(Q39383981)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14982610%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

title

The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamol (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14982610%20AND%20SRC:MED&resulttype=core&format=json

chronic obstructive pulmonary disease

24 November 2019

main subject

rac-salbutamol

0 references

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14982610%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Mark Weatherall

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14982610%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Robert Siebers

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14982610%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

author name string

Alexandra Goldkorn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14982610%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Patricia Diotto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14982610%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Carl Burgess

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14982610%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Shaun Holt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14982610%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

publication date

1 March 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14982610%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14982610%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14982610%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14982610%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

page(s)

102-108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14982610%20AND%20SRC:MED&resulttype=core&format=json

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

24 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2003.00525.X

Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease. SLMT02 Italian Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2003.00525.X

Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2003.00525.X

Onset of action of single doses of formoterol administered via Turbuhaler in patients with stable COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2003.00525.X

Safety of formoterol Turbuhaler at cumulative dose of 90 microg in patients with acute bronchial obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2003.00525.X

Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2003.00525.X

Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2003.00525.X

Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2003.00525.X

Reduced β-adrenoceptor sensitivity in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2003.00525.X

Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2003.00525.X

Quality of life changes in COPD patients treated with salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2003.00525.X

Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2003.00525.X